chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory distress syndrome, Acute respiratory failure, COVID-19, COVID-19 pneumonia
Clinical narrative: 1.  Acute hypoxic hypercapnic respiratory failure, ARDS: -Pulmonology consulted and following. -7/31 intubated -8/4 extubated  -8/16 re-intubated    2.  COVID-pneumonia: -Infectious disease consulted -+7/31 COVID -Decadron, remdesivir completed    3.  Sepsis, septic shock, bacterial PNA: -Receiving antibiotics -Received pressors -sputum cx with yeast, started on diflucan    4.  Recent transesophageal fistula, status post esophageal stent placement, history esophageal cancer: -Prior admission found to have transesophageal fistula and transferred to hospital, hospital placed esophageal stent -ICU team discussed with recent CT surgeon at hospital -Follows with clinic for immunotherapy   5.  AKI: -Monitor labs -Hold nephrotoxic agents, IV fluids  6. Coffee ground emesis: -GI consulted -no plan for EGD at this time d/t high risk re-intubation -cont PPI BID   7. Dysphagia: -unable to tolerate tube feeds, recurrent aspiration -TPN restarted   8. Other chronic medical conditions: History anxiety, history of asthma, history of non-Hodgkin's lymphoma, depression history, hypothyroidism, OSA           History of Present Illness:  Patient is a 46 y.o. female    Despite all medical treatment and attempt to transfer patient to clinic.  Patient continued to decline medically.  Patient and family followed by palliative care and decision made to transition to hospice.  Patient admitted to IP hospice.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Endotracheal intubation, Fungal infection, Haematemesis, Intensive care
Clinical narrative: 1.  Acute hypoxic hypercapnic respiratory failure, ARDS: -Pulmonology consulted and following. -7/31 intubated -8/4 extubated  -8/16 re-intubated    2.  COVID-pneumonia: -Infectious disease consulted -+7/31 COVID -Decadron, remdesivir completed    3.  Sepsis, septic shock, bacterial PNA: -Receiving antibiotics -Received pressors -sputum cx with yeast, started on diflucan    4.  Recent transesophageal fistula, status post esophageal stent placement, history esophageal cancer: -Prior admission found to have transesophageal fistula and transferred to hospital, hospital placed esophageal stent -ICU team discussed with recent CT surgeon at hospital -Follows with clinic for immunotherapy   5.  AKI: -Monitor labs -Hold nephrotoxic agents, IV fluids  6. Coffee ground emesis: -GI consulted -no plan for EGD at this time d/t high risk re-intubation -cont PPI BID   7. Dysphagia: -unable to tolerate tube feeds, recurrent aspiration -TPN restarted   8. Other chronic medical conditions: History anxiety, history of asthma, history of non-Hodgkin's lymphoma, depression history, hypothyroidism, OSA           History of Present Illness:  Patient is a 46 y.o. female    Despite all medical treatment and attempt to transfer patient to clinic.  Patient continued to decline medically.  Patient and family followed by palliative care and decision made to transition to hospice.  Patient admitted to IP hospice.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Pneumonia bacterial, Respiratory failure, Sepsis, Septic shock, Sputum culture positive
Clinical narrative: 1.  Acute hypoxic hypercapnic respiratory failure, ARDS: -Pulmonology consulted and following. -7/31 intubated -8/4 extubated  -8/16 re-intubated    2.  COVID-pneumonia: -Infectious disease consulted -+7/31 COVID -Decadron, remdesivir completed    3.  Sepsis, septic shock, bacterial PNA: -Receiving antibiotics -Received pressors -sputum cx with yeast, started on diflucan    4.  Recent transesophageal fistula, status post esophageal stent placement, history esophageal cancer: -Prior admission found to have transesophageal fistula and transferred to hospital, hospital placed esophageal stent -ICU team discussed with recent CT surgeon at hospital -Follows with clinic for immunotherapy   5.  AKI: -Monitor labs -Hold nephrotoxic agents, IV fluids  6. Coffee ground emesis: -GI consulted -no plan for EGD at this time d/t high risk re-intubation -cont PPI BID   7. Dysphagia: -unable to tolerate tube feeds, recurrent aspiration -TPN restarted   8. Other chronic medical conditions: History anxiety, history of asthma, history of non-Hodgkin's lymphoma, depression history, hypothyroidism, OSA           History of Present Illness:  Patient is a 46 y.o. female    Despite all medical treatment and attempt to transfer patient to clinic.  Patient continued to decline medically.  Patient and family followed by palliative care and decision made to transition to hospice.  Patient admitted to IP hospice.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Alcohol use, Angiogram pulmonary abnormal, Blood gases normal, Blood lactic acid normal
Clinical narrative: Patient is a 23 y.o. male with no past medical history who presented to hospital 8/22/2023 with shortness of breath found to AHRF due to COVID, positive Mono and Strep A pharyngitis, discharged on decadron and amoxicillin to complete full 10 days.    1. Acute Hypoxemic Respiratory Failure: 2/2 to confirmed positive COVID and Strep A. No PE. No prior oxygen requirement, requiring 2L since admit. Significant cervical adenopathy. No stridor on exam. VBG and lactate normal. WBC 15. CT PA and CXR consistent with covid. Home O2 eval without qualification.  2. COVID pneumonia: Confirmed positive 8/22. Symptomatic x 4 days. S/p solmedrol 60 mg 8/22. No remdesivir due to LFT elevation. Tesslon pearls for supportive care.  Decadron x 10 days. 3. Strep A: Appears to have been prescribed amoxicillin outpatient and started on Unasyn in ED. Transitioned to oral Amoxicillin 8/24 to complete full 10 days. 4. Positive Mono spot: supportive care, oral hydration / nutrition. 5. Sepsis POA-  related to #2,#3, #4, supportive care, antibiotics, steroids with improvement. 6. Hyponatremia: Unclear etiology. In the setting of poor oral intake and acute infection. S/p 1 L NS bolus in ED w/ 24 hrs of maintenance fluid, normalized 7. Elevated Liver Enzymes: Unclear etiology. Likely 2/2 to recent increased alcohol intake. Last reported drink 8/18. No abdominal pain. Repeat CMP as outpatient to ensure resolution.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Dyspnoea, Hepatic enzyme increased
Clinical narrative: Patient is a 23 y.o. male with no past medical history who presented to hospital 8/22/2023 with shortness of breath found to AHRF due to COVID, positive Mono and Strep A pharyngitis, discharged on decadron and amoxicillin to complete full 10 days.    1. Acute Hypoxemic Respiratory Failure: 2/2 to confirmed positive COVID and Strep A. No PE. No prior oxygen requirement, requiring 2L since admit. Significant cervical adenopathy. No stridor on exam. VBG and lactate normal. WBC 15. CT PA and CXR consistent with covid. Home O2 eval without qualification.  2. COVID pneumonia: Confirmed positive 8/22. Symptomatic x 4 days. S/p solmedrol 60 mg 8/22. No remdesivir due to LFT elevation. Tesslon pearls for supportive care.  Decadron x 10 days. 3. Strep A: Appears to have been prescribed amoxicillin outpatient and started on Unasyn in ED. Transitioned to oral Amoxicillin 8/24 to complete full 10 days. 4. Positive Mono spot: supportive care, oral hydration / nutrition. 5. Sepsis POA-  related to #2,#3, #4, supportive care, antibiotics, steroids with improvement. 6. Hyponatremia: Unclear etiology. In the setting of poor oral intake and acute infection. S/p 1 L NS bolus in ED w/ 24 hrs of maintenance fluid, normalized 7. Elevated Liver Enzymes: Unclear etiology. Likely 2/2 to recent increased alcohol intake. Last reported drink 8/18. No abdominal pain. Repeat CMP as outpatient to ensure resolution.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Hyponatraemia, Hypophagia, Infection, Liver function test increased, Lymphadenopathy
Clinical narrative: Patient is a 23 y.o. male with no past medical history who presented to hospital 8/22/2023 with shortness of breath found to AHRF due to COVID, positive Mono and Strep A pharyngitis, discharged on decadron and amoxicillin to complete full 10 days.    1. Acute Hypoxemic Respiratory Failure: 2/2 to confirmed positive COVID and Strep A. No PE. No prior oxygen requirement, requiring 2L since admit. Significant cervical adenopathy. No stridor on exam. VBG and lactate normal. WBC 15. CT PA and CXR consistent with covid. Home O2 eval without qualification.  2. COVID pneumonia: Confirmed positive 8/22. Symptomatic x 4 days. S/p solmedrol 60 mg 8/22. No remdesivir due to LFT elevation. Tesslon pearls for supportive care.  Decadron x 10 days. 3. Strep A: Appears to have been prescribed amoxicillin outpatient and started on Unasyn in ED. Transitioned to oral Amoxicillin 8/24 to complete full 10 days. 4. Positive Mono spot: supportive care, oral hydration / nutrition. 5. Sepsis POA-  related to #2,#3, #4, supportive care, antibiotics, steroids with improvement. 6. Hyponatremia: Unclear etiology. In the setting of poor oral intake and acute infection. S/p 1 L NS bolus in ED w/ 24 hrs of maintenance fluid, normalized 7. Elevated Liver Enzymes: Unclear etiology. Likely 2/2 to recent increased alcohol intake. Last reported drink 8/18. No abdominal pain. Repeat CMP as outpatient to ensure resolution.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Mononucleosis heterophile test positive, Pharyngitis streptococcal, SARS-CoV-2 test positive, Sepsis, Streptococcus test positive
Clinical narrative: Patient is a 23 y.o. male with no past medical history who presented to hospital 8/22/2023 with shortness of breath found to AHRF due to COVID, positive Mono and Strep A pharyngitis, discharged on decadron and amoxicillin to complete full 10 days.    1. Acute Hypoxemic Respiratory Failure: 2/2 to confirmed positive COVID and Strep A. No PE. No prior oxygen requirement, requiring 2L since admit. Significant cervical adenopathy. No stridor on exam. VBG and lactate normal. WBC 15. CT PA and CXR consistent with covid. Home O2 eval without qualification.  2. COVID pneumonia: Confirmed positive 8/22. Symptomatic x 4 days. S/p solmedrol 60 mg 8/22. No remdesivir due to LFT elevation. Tesslon pearls for supportive care.  Decadron x 10 days. 3. Strep A: Appears to have been prescribed amoxicillin outpatient and started on Unasyn in ED. Transitioned to oral Amoxicillin 8/24 to complete full 10 days. 4. Positive Mono spot: supportive care, oral hydration / nutrition. 5. Sepsis POA-  related to #2,#3, #4, supportive care, antibiotics, steroids with improvement. 6. Hyponatremia: Unclear etiology. In the setting of poor oral intake and acute infection. S/p 1 L NS bolus in ED w/ 24 hrs of maintenance fluid, normalized 7. Elevated Liver Enzymes: Unclear etiology. Likely 2/2 to recent increased alcohol intake. Last reported drink 8/18. No abdominal pain. Repeat CMP as outpatient to ensure resolution.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: White blood cell count increased
Clinical narrative: Patient is a 23 y.o. male with no past medical history who presented to hospital 8/22/2023 with shortness of breath found to AHRF due to COVID, positive Mono and Strep A pharyngitis, discharged on decadron and amoxicillin to complete full 10 days.    1. Acute Hypoxemic Respiratory Failure: 2/2 to confirmed positive COVID and Strep A. No PE. No prior oxygen requirement, requiring 2L since admit. Significant cervical adenopathy. No stridor on exam. VBG and lactate normal. WBC 15. CT PA and CXR consistent with covid. Home O2 eval without qualification.  2. COVID pneumonia: Confirmed positive 8/22. Symptomatic x 4 days. S/p solmedrol 60 mg 8/22. No remdesivir due to LFT elevation. Tesslon pearls for supportive care.  Decadron x 10 days. 3. Strep A: Appears to have been prescribed amoxicillin outpatient and started on Unasyn in ED. Transitioned to oral Amoxicillin 8/24 to complete full 10 days. 4. Positive Mono spot: supportive care, oral hydration / nutrition. 5. Sepsis POA-  related to #2,#3, #4, supportive care, antibiotics, steroids with improvement. 6. Hyponatremia: Unclear etiology. In the setting of poor oral intake and acute infection. S/p 1 L NS bolus in ED w/ 24 hrs of maintenance fluid, normalized 7. Elevated Liver Enzymes: Unclear etiology. Likely 2/2 to recent increased alcohol intake. Last reported drink 8/18. No abdominal pain. Repeat CMP as outpatient to ensure resolution.
Age: 25.0
Sex: F
Vaccine: COVID19-2
Symptoms: Discontinued product administered
Clinical narrative: Patient was administered Moderna's bivalent booster on 9/14/2023. The FDA pulled the authorization for this vaccine on 9/11/23
Age: 43.0
Sex: F
Vaccine: FLU4
Symptoms: Defaecation urgency, Faecal volume decreased, Hot flush, Nausea, Pyrexia
Clinical narrative: About 36 hours after receiving the vaccine (5PM Sunday to 4:30AM Tuesday), I woke up with a slight fever, slight nausea, and urgent need to empty my bowls (no diarrhea, just constant emptying of bowels in smaller amounts). This progressed for about 5  hours (9:30-10AM) until I had an extreme hot flash/fever and severe nausea for about 30 minutes.  I was only drinking water and eating Tums ant-acid the entire time. By about 10AM the extreme nausea/fever wave had passed and I was finally able to eat something to settle my stomach and after about another 30 minutes, I was back to normal feeling.
Age: 85.0
Sex: U
Vaccine: COVID19
Symptoms: Acute respiratory failure, Asthenia, Bundle branch block left, COVID-19, Cardiac ventriculogram left abnormal
Clinical narrative: Patient is an 87 year old  male with a history of Atrial Fibrillation/LBBB, CAD, HFrEF, Alzheimer's Dementia, who presented to hospital 8/24/23 with shortness of breath and new onset fatigue. Found to be hypoxic with fever per EMS with COVID-19 testing positive in the ED.    1. Acute Hypoxemic Respiratory Failure: Reported per EMS, 70% on RA but unclear if accurate. CXR in ED with densities noted in lung bases with bilateral pleural effusions. Goal sat to keep greater than 92%, currently on supplemental Oxygen since morning of 8/25/23. Restarted decadron, promote IS, wean as able. 2. COVID-19 infection: COVID-19 positive in ED 8/24/23. Symptoms of dyspnea, cough, fevers. Initially deemed hypoxic by EMS but no re  . Initially deemed hypoxic by EMS but no requirement on admission. Decadron initiated X10 days. Evaluated by ID, deemed a candidate for Remdesivir and so ordered, started 8/26/23.  3. Age related debility: PT/OT followed, noted reduced mobility with recommendations for rollator walker at discharge. 4. Chronic HFrEF: Known history with ischemic Cardiomyopathy. LHC with LV gram Nov 2021 noted EF 20-25% with severe diffuse hypokinesia of the LV. CXR in ED with pleural effusions noted similar to May 2023. Other than this, he clinically appeared dry on admission. NT Pro BNP 5501. Betablocker continued with hold parameters. ARB and diuretics at discharge. 5. Atrial Fibrillation: per history. CHA2DS2-VASc (5). Continued home Eliquis and Betablocker/ 6. CAD: Extensive ASCVD with history of CABG and prior intervention to RCA. Home ASA, statin, Betablocker and Eliquis continued.  7. LBBB: Known history  of this, ECG on admission re-demonstrated.  8. Primary Hypertension: per history, home meds at discharge. 9. Alzheimer's Dementia: per history. A/Ox2 on admission. Continued home meds.  10. Seizure Disorder: per history, continued home meds.  11. Code status: DNR CC per son's request, but continue current level of care.
Age: 85.0
Sex: U
Vaccine: COVID19
Symptoms: Catheterisation cardiac abnormal, Chest X-ray abnormal, Condition aggravated, Cough, Diuretic therapy
Clinical narrative: Patient is an 87 year old  male with a history of Atrial Fibrillation/LBBB, CAD, HFrEF, Alzheimer's Dementia, who presented to hospital 8/24/23 with shortness of breath and new onset fatigue. Found to be hypoxic with fever per EMS with COVID-19 testing positive in the ED.    1. Acute Hypoxemic Respiratory Failure: Reported per EMS, 70% on RA but unclear if accurate. CXR in ED with densities noted in lung bases with bilateral pleural effusions. Goal sat to keep greater than 92%, currently on supplemental Oxygen since morning of 8/25/23. Restarted decadron, promote IS, wean as able. 2. COVID-19 infection: COVID-19 positive in ED 8/24/23. Symptoms of dyspnea, cough, fevers. Initially deemed hypoxic by EMS but no re  . Initially deemed hypoxic by EMS but no requirement on admission. Decadron initiated X10 days. Evaluated by ID, deemed a candidate for Remdesivir and so ordered, started 8/26/23.  3. Age related debility: PT/OT followed, noted reduced mobility with recommendations for rollator walker at discharge. 4. Chronic HFrEF: Known history with ischemic Cardiomyopathy. LHC with LV gram Nov 2021 noted EF 20-25% with severe diffuse hypokinesia of the LV. CXR in ED with pleural effusions noted similar to May 2023. Other than this, he clinically appeared dry on admission. NT Pro BNP 5501. Betablocker continued with hold parameters. ARB and diuretics at discharge. 5. Atrial Fibrillation: per history. CHA2DS2-VASc (5). Continued home Eliquis and Betablocker/ 6. CAD: Extensive ASCVD with history of CABG and prior intervention to RCA. Home ASA, statin, Betablocker and Eliquis continued.  7. LBBB: Known history  of this, ECG on admission re-demonstrated.  8. Primary Hypertension: per history, home meds at discharge. 9. Alzheimer's Dementia: per history. A/Ox2 on admission. Continued home meds.  10. Seizure Disorder: per history, continued home meds.  11. Code status: DNR CC per son's request, but continue current level of care.
Age: 85.0
Sex: U
Vaccine: COVID19
Symptoms: Dyspnoea, Ejection fraction decreased, Electrocardiogram abnormal, Fatigue, Hypoxia
Clinical narrative: Patient is an 87 year old  male with a history of Atrial Fibrillation/LBBB, CAD, HFrEF, Alzheimer's Dementia, who presented to hospital 8/24/23 with shortness of breath and new onset fatigue. Found to be hypoxic with fever per EMS with COVID-19 testing positive in the ED.    1. Acute Hypoxemic Respiratory Failure: Reported per EMS, 70% on RA but unclear if accurate. CXR in ED with densities noted in lung bases with bilateral pleural effusions. Goal sat to keep greater than 92%, currently on supplemental Oxygen since morning of 8/25/23. Restarted decadron, promote IS, wean as able. 2. COVID-19 infection: COVID-19 positive in ED 8/24/23. Symptoms of dyspnea, cough, fevers. Initially deemed hypoxic by EMS but no re  . Initially deemed hypoxic by EMS but no requirement on admission. Decadron initiated X10 days. Evaluated by ID, deemed a candidate for Remdesivir and so ordered, started 8/26/23.  3. Age related debility: PT/OT followed, noted reduced mobility with recommendations for rollator walker at discharge. 4. Chronic HFrEF: Known history with ischemic Cardiomyopathy. LHC with LV gram Nov 2021 noted EF 20-25% with severe diffuse hypokinesia of the LV. CXR in ED with pleural effusions noted similar to May 2023. Other than this, he clinically appeared dry on admission. NT Pro BNP 5501. Betablocker continued with hold parameters. ARB and diuretics at discharge. 5. Atrial Fibrillation: per history. CHA2DS2-VASc (5). Continued home Eliquis and Betablocker/ 6. CAD: Extensive ASCVD with history of CABG and prior intervention to RCA. Home ASA, statin, Betablocker and Eliquis continued.  7. LBBB: Known history  of this, ECG on admission re-demonstrated.  8. Primary Hypertension: per history, home meds at discharge. 9. Alzheimer's Dementia: per history. A/Ox2 on admission. Continued home meds.  10. Seizure Disorder: per history, continued home meds.  11. Code status: DNR CC per son's request, but continue current level of care.
Age: 85.0
Sex: U
Vaccine: COVID19
Symptoms: Lung disorder, Mobility decreased, N-terminal prohormone brain natriuretic peptide increased, Pleural effusion, Pyrexia
Clinical narrative: Patient is an 87 year old  male with a history of Atrial Fibrillation/LBBB, CAD, HFrEF, Alzheimer's Dementia, who presented to hospital 8/24/23 with shortness of breath and new onset fatigue. Found to be hypoxic with fever per EMS with COVID-19 testing positive in the ED.    1. Acute Hypoxemic Respiratory Failure: Reported per EMS, 70% on RA but unclear if accurate. CXR in ED with densities noted in lung bases with bilateral pleural effusions. Goal sat to keep greater than 92%, currently on supplemental Oxygen since morning of 8/25/23. Restarted decadron, promote IS, wean as able. 2. COVID-19 infection: COVID-19 positive in ED 8/24/23. Symptoms of dyspnea, cough, fevers. Initially deemed hypoxic by EMS but no re  . Initially deemed hypoxic by EMS but no requirement on admission. Decadron initiated X10 days. Evaluated by ID, deemed a candidate for Remdesivir and so ordered, started 8/26/23.  3. Age related debility: PT/OT followed, noted reduced mobility with recommendations for rollator walker at discharge. 4. Chronic HFrEF: Known history with ischemic Cardiomyopathy. LHC with LV gram Nov 2021 noted EF 20-25% with severe diffuse hypokinesia of the LV. CXR in ED with pleural effusions noted similar to May 2023. Other than this, he clinically appeared dry on admission. NT Pro BNP 5501. Betablocker continued with hold parameters. ARB and diuretics at discharge. 5. Atrial Fibrillation: per history. CHA2DS2-VASc (5). Continued home Eliquis and Betablocker/ 6. CAD: Extensive ASCVD with history of CABG and prior intervention to RCA. Home ASA, statin, Betablocker and Eliquis continued.  7. LBBB: Known history  of this, ECG on admission re-demonstrated.  8. Primary Hypertension: per history, home meds at discharge. 9. Alzheimer's Dementia: per history. A/Ox2 on admission. Continued home meds.  10. Seizure Disorder: per history, continued home meds.  11. Code status: DNR CC per son's request, but continue current level of care.
Age: 85.0
Sex: U
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Ventricular hypokinesia
Clinical narrative: Patient is an 87 year old  male with a history of Atrial Fibrillation/LBBB, CAD, HFrEF, Alzheimer's Dementia, who presented to hospital 8/24/23 with shortness of breath and new onset fatigue. Found to be hypoxic with fever per EMS with COVID-19 testing positive in the ED.    1. Acute Hypoxemic Respiratory Failure: Reported per EMS, 70% on RA but unclear if accurate. CXR in ED with densities noted in lung bases with bilateral pleural effusions. Goal sat to keep greater than 92%, currently on supplemental Oxygen since morning of 8/25/23. Restarted decadron, promote IS, wean as able. 2. COVID-19 infection: COVID-19 positive in ED 8/24/23. Symptoms of dyspnea, cough, fevers. Initially deemed hypoxic by EMS but no re  . Initially deemed hypoxic by EMS but no requirement on admission. Decadron initiated X10 days. Evaluated by ID, deemed a candidate for Remdesivir and so ordered, started 8/26/23.  3. Age related debility: PT/OT followed, noted reduced mobility with recommendations for rollator walker at discharge. 4. Chronic HFrEF: Known history with ischemic Cardiomyopathy. LHC with LV gram Nov 2021 noted EF 20-25% with severe diffuse hypokinesia of the LV. CXR in ED with pleural effusions noted similar to May 2023. Other than this, he clinically appeared dry on admission. NT Pro BNP 5501. Betablocker continued with hold parameters. ARB and diuretics at discharge. 5. Atrial Fibrillation: per history. CHA2DS2-VASc (5). Continued home Eliquis and Betablocker/ 6. CAD: Extensive ASCVD with history of CABG and prior intervention to RCA. Home ASA, statin, Betablocker and Eliquis continued.  7. LBBB: Known history  of this, ECG on admission re-demonstrated.  8. Primary Hypertension: per history, home meds at discharge. 9. Alzheimer's Dementia: per history. A/Ox2 on admission. Continued home meds.  10. Seizure Disorder: per history, continued home meds.  11. Code status: DNR CC per son's request, but continue current level of care.
Age: 58.0
Sex: M
Vaccine: VARZOS
Symptoms: Dyspnoea, Myalgia, Pain in extremity, Pyrexia, Respiratory tract congestion
Clinical narrative: Patient reported arms and legs hurt, body hurts to touch, fever, congestion, and trouble breathing, he could get his breath but his muscles hurt when he breathed in,  informed patient to seek medical care by either going to urgent care or to the ER whichever one the patient thought they needed to go.  Patient said they were going to go seek medical care.  I thought the patient should be checked out due to him reporting breathing problems
Age: 58.0
Sex: M
Vaccine: VARZOS
Symptoms: Tenderness
Clinical narrative: Patient reported arms and legs hurt, body hurts to touch, fever, congestion, and trouble breathing, he could get his breath but his muscles hurt when he breathed in,  informed patient to seek medical care by either going to urgent care or to the ER whichever one the patient thought they needed to go.  Patient said they were going to go seek medical care.  I thought the patient should be checked out due to him reporting breathing problems
Age: 82.0
Sex: F
Vaccine: UNK
Symptoms: Dizziness, Presyncope
Clinical narrative: repeated episodes of lightheadedness with near-syncopal event and ED visit
Age: 18.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Electrocardiogram abnormal, Foetal monitoring, Maternal exposure before pregnancy, Oxygen saturation decreased
Clinical narrative: Patient is a 19 y.o. female patient of Dr with an uncomplicated pregnancy who was admitted for maternal tachycardia in the setting of an active COVID infection. On admission patient was tachycardic to the 130s and was given a 1L bolus. EKG showed sinus tachycardia. Required 1L of oxygen overnight due to desaturation to 94%. On discharge, tachycardia resolved, required no oxygen requirement and patient was asymptomatic. An MFM ultrasound was scheduled on 9/5 at 10:30 am. She also has a follow up with Dr on 9/5. She was discharged home with return precautions.      Discharge Diagnoses: * Coronavirus infection Assessment & Plan  Patient is a 19 y.o. G1P0 at 28w3d who presents with with uncomplicated pregnancy who is admitted to hospital with tachycardia in the setting of COVID infection.    Covid w/ Maternal Tachycardia - Tachycardia has resolved in low 110s, NT, AF   - 99% on 1L of oxygen- desatted to 94 when sleeping  - s/p 1,000 mL fluid bolus - Growth US for further fetal evaluation- needs scheduled  - Offered Paxlovid but patient declined.     Fetal wellbeing -cEFM/Toco  -Preg diet  -BMZ: held    Dispo: Continue to monitor. Tachycardia has resolved, deescalate this morning. Oxygen requirement overnight, attempt to wean when patient wakes up. Consider echo if becomes more symptomatic or tachycardia returns.
Age: 18.0
Sex: F
Vaccine: COVID19-2
Symptoms: Primigravida, Sinus tachycardia, Tachycardia
Clinical narrative: Patient is a 19 y.o. female patient of Dr with an uncomplicated pregnancy who was admitted for maternal tachycardia in the setting of an active COVID infection. On admission patient was tachycardic to the 130s and was given a 1L bolus. EKG showed sinus tachycardia. Required 1L of oxygen overnight due to desaturation to 94%. On discharge, tachycardia resolved, required no oxygen requirement and patient was asymptomatic. An MFM ultrasound was scheduled on 9/5 at 10:30 am. She also has a follow up with Dr on 9/5. She was discharged home with return precautions.      Discharge Diagnoses: * Coronavirus infection Assessment & Plan  Patient is a 19 y.o. G1P0 at 28w3d who presents with with uncomplicated pregnancy who is admitted to hospital with tachycardia in the setting of COVID infection.    Covid w/ Maternal Tachycardia - Tachycardia has resolved in low 110s, NT, AF   - 99% on 1L of oxygen- desatted to 94 when sleeping  - s/p 1,000 mL fluid bolus - Growth US for further fetal evaluation- needs scheduled  - Offered Paxlovid but patient declined.     Fetal wellbeing -cEFM/Toco  -Preg diet  -BMZ: held    Dispo: Continue to monitor. Tachycardia has resolved, deescalate this morning. Oxygen requirement overnight, attempt to wean when patient wakes up. Consider echo if becomes more symptomatic or tachycardia returns.
Age: 49.0
Sex: F
Vaccine: FLU4
Symptoms: Arthralgia, Injection site erythema, Injection site pain, Injection site swelling, Neck pain
Clinical narrative: Teammate had vaccine 9/19/23. On 9/20/23 had general achiness in joints, neck and shoulders. On 9/21/23 woke up with redness, swelling, and tender to touch site just below injection site.  Area measures approximately 3x4 inches.  Teammate does not feel needs to seek medical care at this time.
Age: 1.25
Sex: M
Vaccine: HPV9
Symptoms: Wrong product administered
Clinical narrative: Immunization was given in mistake.
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Fatigue, Injection site pain, Injection site swelling, Lymphadenopathy, Myalgia
Clinical narrative: PAin and swelling at injection site, Body Aches and muscle pain and fatigue. Lymoh node swelling under left axillary, left cervical region.
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain
Clinical narrative: PAin and swelling at injection site, Body Aches and muscle pain and fatigue. Lymoh node swelling under left axillary, left cervical region.
Age: 67.0
Sex: F
Vaccine: FLUA4
Symptoms: Injection site erythema
Clinical narrative: Patient reporting an injection site red mark, much larger than she has ever had before, bigger than a silver dollar per patient and thinks it may be warm.
Age: 70.0
Sex: M
Vaccine: RSV
Symptoms: Dizziness, Dysstasia, Hypertension, Mobility decreased, Muscular weakness
Clinical narrative: High blood pressure 177/111. weakness in legs and arms.  dizziness. can't get up from sitting position or laying position. if on the floor, can't get up from that position.  Outcome: most adverse events ended about 2 and 1/2 days later. Adverse event started about 1 to 2 hours after injection.
Age: 75.0
Sex: M
Vaccine: FLUA4
Symptoms: Extra dose administered, No adverse event
Clinical narrative: 9/20/23 patient came into pharmacy flu clinic to get flu shot, received it, and then left the pharmacy. When we tried to bill the insurance, the insurance rejected the claim indicating that patient already received the flu shot at another pharmacy 9/6/23, which was confirmed with pharmacy. Patient received 2 flu shots in a month timeframe. When we spoke to the patient via phone today 9/21/23, patient was confused and said he didn't remembering getting flu shot at other pharmacy. His story was not consistent. Patient reports of no ADR reports, feeling good.
Age: 14.0
Sex: M
Vaccine: HPV9
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient has not had an adverse reaction yet but patient has been given this vaccine 6 times now when he should have only received 2 doses.
Age: 26.0
Sex: F
Vaccine: FLUA4
Symptoms: Exposure during pregnancy, Product administered to patient of inappropriate age
Clinical narrative: I went to the vaccine inventory fridge to get a flu vaccine, after getting vaccine I went to a provider to confirm I was giving the correct vaccine. the provider confirmed it was the right vaccine, gave pt vaccine , pt left I saw something was wrong with the vaccine, realized it wasn't the same display as another flu vaccine I had on my desk, I went to the nurses to check why vaccine was different, nurses told me it was a high dose vaccine which is for 65+ age pts and that's why it was different then the regular dose I had, I called pt whom is currently pregnant with her second child, pt is currently 32 weeks and 4 days pregnant expected to give birth November 12, I made her aware of mistake, pt reassured me it was okay and was made aware of side effects.
Age: 49.0
Sex: M
Vaccine: FLU4
Symptoms: Blood pressure immeasurable, Cardio-respiratory arrest, Unresponsive to stimuli
Clinical narrative: RN identified pt with full name and DOB. Pt was alert and RN administered the flu vaccine. Pt tolerated it well. RN documented the flu vaccine in nurse office. Pt's family was in room and alerted staff to help as pt had become unresponsive. RN went to room and the doctor was there along with other nurses from the unit. Rn was not a part of the code. Witnessed staff attempt to gain vitals, and was unable to get blood pressure. Pt was breathing and had a pulse. A staff member called 911.  An ambulance came and transport pt to ED.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine stored in unapproved storage unit
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine stored in unapproved storage unit
Age: 65.0
Sex: F
Vaccine: RSV
Symptoms: Exposure via skin contact, Syringe issue, Underdose
Clinical narrative: WHEN GIVING THE VACCINATION, LIQUID LEAKED OUT BETWEEN THE NEEDLE HUB AND THE LUER LOCK SYRINGE.  WE BOTH NOTICED THAT THERE WAS WETNESS LEAKING DOWN HER ARM.  AT THE TIME I DID NOT REVACCINATE.  I VERIFIED WITH THE CDC THAT I COULD REVACCINATE AND CALLED THE PATIENT WHO WILL BE COMING IN NEXT WEEK.
Age: 78.0
Sex: F
Vaccine: FLU4, RSV
Symptoms: Tremor
Clinical narrative: around midnight the night after she got the vaccine she had a muscle shaking in the torso the same side as vaccine was given and then throughout the body for about an hour and half. did not seek medical care or take anything but it did go away on it's own.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine stored in unapproved storage unit
Age: 52.0
Sex: F
Vaccine: FLU4
Symptoms: Diarrhoea, Fatigue
Clinical narrative: Fatique and Diarrhea x 4 days
Age: 36.0
Sex: F
Vaccine: UNK
Symptoms: Swelling
Clinical narrative: developed a lump in neck after Tdap vaccine administered by he PCP
Age: 66.0
Sex: F
Vaccine: PNC20
Symptoms: Injected limb mobility decreased, Injection site haemorrhage, Injection site hypoaesthesia, Injection site joint pain, Injection site pain
Clinical narrative: At 8/11 follow-up visit with primary care physician, patient stated felt like nerve was possibly hit when vaccine was administered. Notes shoulder pain and numbness with difficulty raising right arm after vaccination was received. Reports that entire shoulder joint and neck hurt for several weeks after immunization. Reports site bled quite a bit after administration. Notes continued symptoms since vaccination, but symptoms have improved and leveled off.
Age: 66.0
Sex: F
Vaccine: PNC20
Symptoms: Neck pain
Clinical narrative: At 8/11 follow-up visit with primary care physician, patient stated felt like nerve was possibly hit when vaccine was administered. Notes shoulder pain and numbness with difficulty raising right arm after vaccination was received. Reports that entire shoulder joint and neck hurt for several weeks after immunization. Reports site bled quite a bit after administration. Notes continued symptoms since vaccination, but symptoms have improved and leveled off.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine stored in unapproved storage unit
Age: 70.0
Sex: F
Vaccine: FLUA4, RSV
Symptoms: Blood test, Computerised tomogram, Deafness unilateral, Magnetic resonance imaging, Vertigo
Clinical narrative: Vertigo and hearing loss in one ear
Age: 69.0
Sex: F
Vaccine: FLU4
Symptoms: Asthma, Condition aggravated, Injection site erythema, Injection site induration, Injection site pruritus
Clinical narrative: PT PRESENTED TO HEALTH DEPT ON 09/21/2023, STATED THAT HER VACCINE REACTION STARTED THE EVENING OF 09/19/2023 INCLUDING REDNESS THE SIZE OF A BASEBALL NOTED AT THE INJECTION SITE, A LINE OF HIVES ALSO NOTED AT INJECTION SITE, SITE WAS HARD AND WARM TO THE TOUCH, PT STATES THAT THE INJECTION SITE ITCHES ALL SYMPTOMS REPORTED ARE STILL PRESENT TODAY 09/21/2023; PT REPORTED THAT ON 09/20/2023 SHE NOTICED A FLARE UP IN HER ASTHMA; PT NOT IS DISTRESS AS OF 09/21/2023; INTRUCTED PT TO CONTACT PCP DR TO SCHEDULE APPT FOR TODAY 09/21/2023, IF PCP IS UNAVAILABLE PT WAS ADVISED TO GO TO WALK IN CARE FOR FURTHER FOLLOW-UP REGARDING REACTION, PT VERBALIZED UNDERSTANDING. INSTRUCTED PT TO PHONE BACK LATER TODAY 09/21/2023 TO UPDATE US ON HER CONDITION; HAVE NOT HEARD UPDATE YET AS OF 1626 ON 09/21/2023.
Age: 69.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site urticaria, Injection site warmth
Clinical narrative: PT PRESENTED TO HEALTH DEPT ON 09/21/2023, STATED THAT HER VACCINE REACTION STARTED THE EVENING OF 09/19/2023 INCLUDING REDNESS THE SIZE OF A BASEBALL NOTED AT THE INJECTION SITE, A LINE OF HIVES ALSO NOTED AT INJECTION SITE, SITE WAS HARD AND WARM TO THE TOUCH, PT STATES THAT THE INJECTION SITE ITCHES ALL SYMPTOMS REPORTED ARE STILL PRESENT TODAY 09/21/2023; PT REPORTED THAT ON 09/20/2023 SHE NOTICED A FLARE UP IN HER ASTHMA; PT NOT IS DISTRESS AS OF 09/21/2023; INTRUCTED PT TO CONTACT PCP DR TO SCHEDULE APPT FOR TODAY 09/21/2023, IF PCP IS UNAVAILABLE PT WAS ADVISED TO GO TO WALK IN CARE FOR FURTHER FOLLOW-UP REGARDING REACTION, PT VERBALIZED UNDERSTANDING. INSTRUCTED PT TO PHONE BACK LATER TODAY 09/21/2023 TO UPDATE US ON HER CONDITION; HAVE NOT HEARD UPDATE YET AS OF 1626 ON 09/21/2023.
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Discontinued product administered
Clinical narrative: Patient was administered Moderna's bivalent booster on 9/14/2023. The FDA pulled the authorization for this vaccine on 9/11/2023
Age: 1.75
Sex: M
Vaccine: DTPPVHBHPB, HEPA, MMR, VARCEL, DTPPVHBHPB, HEPA, MMR, VARCEL
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: patient was given MMR in the left thigh, the evening of the vaccine the vaccine site got red and swollen to the size of a quarter by the next day it was swollen to baseball size
Age: 1.75
Sex: M
Vaccine: DTPPVHBHPB, HEPA, MMR, VARCEL, DTPPVHBHPB, HEPA, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: patient was given MMR in the left thigh, the evening of the vaccine the vaccine site got red and swollen to the size of a quarter by the next day it was swollen to baseball size
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Renal pain
Clinical narrative: Headache, kidney pain, stomach queasy, fatigue
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine stored in unapproved storage unit
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Pyrexia
Clinical narrative: 100.06 fever, body aches, sore arm.  Next morning after receiving the new 2023 Moderna Spikevax.
Age: 68.0
Sex: M
Vaccine: COVID19-2
Symptoms: Discontinued product administered
Clinical narrative: Patient was administered Moderna's bivalent booster on 9/14/2023. The FDA pulled the authorization for this vaccine on 9/11/2023
Age: 0.17
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV1
Symptoms: CSF test, Eye discharge, Flow cytometry, Full blood count, Lumbar puncture
Clinical narrative: Vaccines proceeded as expected.  About a month later, patient presented with eye drainage and was treated with eye ointment.  He did not get better, and developed a fever on 7/14/23.  He looked pale and unwell and was admitted to the hospital.  Workup revealed acute myelogenous leukemia with spread to the CSF.  Given the rapid prorgression to leukemia, parents requested that we report to VAERS in case there were any correlation between timing of vaccination and onset of his leukemia.
Age: 0.17
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV1
Symptoms: Malaise, Myeloid leukaemia, Pallor, Pyrexia
Clinical narrative: Vaccines proceeded as expected.  About a month later, patient presented with eye drainage and was treated with eye ointment.  He did not get better, and developed a fever on 7/14/23.  He looked pale and unwell and was admitted to the hospital.  Workup revealed acute myelogenous leukemia with spread to the CSF.  Given the rapid prorgression to leukemia, parents requested that we report to VAERS in case there were any correlation between timing of vaccination and onset of his leukemia.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine stored in unapproved storage unit
Age: 3.0
Sex: F
Vaccine: COVID19-2
Symptoms: Discontinued product administered
Clinical narrative: Patient was administered Moderna's bivalent booster on 9/14/2023. The FDA pulled the authorization for this vaccine on 9/11/2023
Age: 65.0
Sex: F
Vaccine: RSV
Symptoms: Injection site pain
Clinical narrative: Patient described progressively worse burning/pain at injection site. Patient did admit to rubbing the should as a nurse told her to do this years ago.
Age: 7.0
Sex: F
Vaccine: COVID19-2
Symptoms: Product storage error
Clinical narrative: Patient was administered Moderna's bivalent booster on 9/14/2023. The FDA pulled the authorization for this vaccine on 9/11/2023
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine stored in unapproved storage unit
Age: 19.0
Sex: F
Vaccine: FLUR4
Symptoms: Urticaria
Clinical narrative: Patient called after getting home and stated she has hives on her left arm at this point. She was instructed to take benadryl and to follow up with provider if symptoms get worse.
Age: 67.0
Sex: F
Vaccine: FLU4
Symptoms: No adverse event
Clinical narrative: No adverse reaction to patient
Age: 13.0
Sex: F
Vaccine: FLU4, HPV9, MENB, MNQ
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Patient was scheduled to receive 3 vaccines, one of which was the Meningitis conjugate (Menquadfi) vaccine, but Meningitis B (Trumenba) vaccine was given in error.  Meningitis conjugate was then given once error was identified.  Patient tolerated all vaccines well and there were no side effects observed within 15 minutes of receiving all 4 vaccines.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine stored in unapproved storage unit
Age: 26.0
Sex: F
Vaccine: TDAP
Symptoms: Extra dose administered, Paraesthesia
Clinical narrative: Medication error occurred. Patient had received Tdap vaccine on 9/14/23 and was given second, accidental dose on 9/19/23. Two hours after administration, began to complain of tingling along the ulnar nerve distribution. Later that evening she began to experience tingling in the right foot.
Age: 45.0
Sex: F
Vaccine: FLU4
Symptoms: Headache, Myalgia, Pain, Pain in extremity
Clinical narrative: Complained of sore arm and headache after injection.  Had taken Tylenol and Ibuprofen, headache resolved but arm muscle pain persisted especially with movement. No reported swelling, redness, or excessive warmness noted to injection site.
Age: 44.0
Sex: F
Vaccine: PPV
Symptoms: Dizziness, Dyspnoea, Erythema, Headache, Nausea
Clinical narrative: Patient developed redness and itching ~10 minutes after administration of vaccine. After additional 10 minutes, patient complained of dizziness, headache, and difficulty breathing. Patient noted nausea after administration of rescue medications. Patient observed in emergency department and discharged in stable condition ~3 hours later. Patient noted generalized body aches the following day during follow-up call.
Age: 44.0
Sex: F
Vaccine: PPV
Symptoms: Pain, Pruritus, Tryptase
Clinical narrative: Patient developed redness and itching ~10 minutes after administration of vaccine. After additional 10 minutes, patient complained of dizziness, headache, and difficulty breathing. Patient noted nausea after administration of rescue medications. Patient observed in emergency department and discharged in stable condition ~3 hours later. Patient noted generalized body aches the following day during follow-up call.
Age: 7.0
Sex: M
Vaccine: MMR
Symptoms: Expired product administered, No adverse event
Clinical narrative: No additional AE reported; an expired dose of MMR-II was administered to a patient; This spontaneous report as received from a medical assistant referring to an unspecified patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies, concurrent conditions and concomitant medications were not reported.   On 21-AUG-2023, the patient was vaccinated with expired mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) recombinant Human albumin (rHA) lot # U024229 with expiration date 04-AUG-2023, for prophylaxis (strength, dose, route of administration and anatomical location were not reported) (Expired product administered). No additional adverse event (AE) was reported and also no adverse effects were reported. This is a non-valid case as no patient's identifiers were provided.   Follow up information has been received from a nurse practitioner regarding a 7-year-old male patient on 14-SEP-2023. The patient had non illness at time of vaccination nor pre-existing physician-diagnosed allergies, birth defects, medical conditions. The vaccine was purchased with public funds and the patient was vaccinated in a public health clinic.  On 21-AUG-2023, the patient was vaccinated with first expired mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) recombinant Human albumin (rHA) (lot # U024229 with expiration date 04-AUG-2023) (previously reported), administered subcutaneously through left arm. No previous doses of this vaccine was administered before.  Outcome for the event was reported as recovered. It was reported that at error occurred at the point of the administration of the vaccine. This event was reported previously to health department. The patient had no response to the administration of the expired vaccine.  This case was previously considered non-valid, but upon new follow-up information received patient's identifiers were provided.
Sex: U
Vaccine: MMR, TDAP, VARCEL
Symptoms: No adverse event, Product preparation error
Clinical narrative: No additional AE; it's unclear if the nurse reconstituted the vaccine ( MMR II or VARIVAX) with DILUENT or if she mistakenly used the vial of BOOSTRIX in its place.; it's unclear if the nurse reconstituted the vaccine ( MMR II or VARIVAX) with DILUENT or if she mistakenly used the vial of BOOSTRIX in its place.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. Information regarding the patient's concurrent conditions, medical history, historical drugs and concomitant therapies was not provided.  On an unknown date, the patient possibly received measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection, 0.5ml/ series, expiration date: 20-JUN-2024, administered for prophylaxis (strength, lot #, and route of administration were not provided) or varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5ml/ series, lot #w011622, expiration date: 06-APR-2024, administered for prophylaxis (strength, and route of administration were not provided) along with  diphtheria vaccine toxoid, pertussis vaccine acellular 3-component, tetanus vaccine toxoid (BOOSTRIX). It was unclear if the nurse reconstituted the vaccine with MERCK STERILE DILUENT or if she mistakenly used the vial of diphtheria vaccine toxoid, pertussis vaccine acellular 3-component, tetanus vaccine toxoid (BOOSTRIX) in its place (Product preparation error, product confusion). No other adverse events were reported by the patient in the form of side effects.
Age: 77.0
Sex: U
Vaccine: PPV
Symptoms: Expired product administered, No adverse event
Clinical narrative: No additional AE/; HCP called to report inadvertent administration of expired PNEUMOVAX 23 to a patient. Product expired on 08/21/2023 and was administered on 08/28/2023. No additional AE/PQC.; This spontaneous report was received from Other Health Professional and refers to a 77-year-old patient of unknown gender. The patient's concurrent conditions, concomitant therapies, historical drugs and historical conditions were not reported.  On 28-AUG-2023, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, expiration date: 21-AUG-2023, administered for prophylaxis (strength, dose, lot #, anatomical site of administration and route of administration were not provided) (expired vaccine used). No additional AE (no adverse event).